Trouble logging in? Forgot password? We can help!
215-685-6784
215-238-6944
Fill out both forms, then either email or fax them to us at the contact above.
Provider? Stay in the know
Get the newest information from the Immunization Program right in your inbox!
Sign upThe Immunization Champion Award, hosted by the Association of Immunization Managers (AIM) and funded by the Centers for Disease Control and Prevention (CDC), recognizes individuals doing an exemplary job or going above and beyond to promote or foster immunizations in their communities for children and adults. The award...
2025-2026 VFC & VFAAR influenza products will be available to order soon. Make sure your office is ready! Starting Tuesday, August 12, 2025: FluLaval and Flucelvax will be available to order for your VFC-eligible patients. FluLaval will be available to order for your VFAAR-eligible patients. Complete a return in PhilaVax for any...
Join us for an informative virtual session on respiratory viruses. This session is for both primary care physicians (PCPs) and other vaccine providers to learn more about: respiratory syncytial virus (RSV) influenza COVID-19 vaccine ordering, storage, and administration information Infectious disease expert Dr. Mayssa Abuali will give an overview of...
Nirsevimab (Beyfortus) ordering will begin in August for the 2025-2026 season. Nirsevimab (Beyfortus), a monoclonal antibody immunization used to prevent RSV infection in infants and young children, can be administered from October 1, 2025, to March 31, 2026. The CDC plans to continue releasing nirsevimab (Beyfortus) through...
In the face of rapidly shifting vaccine policies and public uncertainty, it’s more important than ever for healthcare providers to be equipped with tools that foster trust and clarity around vaccination. We’ve developed strategies to support your conversations with patients—strategies that address misconceptions, center patient concerns,...
Join us for the Philadelphia Immunization Coalition (PIC) adult-focused conference on June 3, 2025, from 8:00 AM – 3:30 PM at the College of Physicians in Philadelphia. Keynote speakers include: Richard Hughes IV, JD, MPH on healthcare and the political climate Paul Offit, MD on vaccine education Topics include: Hepatitis...
With ongoing measles outbreaks in the United States, all healthcare professionals should stay alert for measles cases, especially during the upcoming summer travel season, and particularly in unvaccinated patients. To help providers and clinics stay prepared, CDC’s Project Firstline is hosting a webinar on May...
National Infant Immunization Week (NIIW) highlights the importance of protecting children two years and younger from vaccine-preventable diseases. Research consistently shows that healthcare professionals are the most trusted source of vaccine information for parents. Take this opportunity to speak about the importance of timely vaccination. Dr. Mayssa Abuali, Immunization Program Medical...
There is a growing number of measles cases in the United States. Most of these cases come from unvaccinated U.S. travelers who are infected with measles while traveling to other countries. Make sure your family and community know the risks of measles and how to...
This email marks the launch of the nomination period for the Immunization Champion Award! We look forward to receiving your nominations and selecting a 2025 Immunization Champion for Philadelphia. The Immunization Champion Award is a national award program hosted by the Association of Immunization Managers (AIM)...
It's Adolescent Immunization Action Week (AIAW)! Take action and access these resources. Adolescent Immunization Action Week (AIAW) reminds us to keep adolescents up-to-date on immunizations that protect against potentially life-threatening diseases like meningitis, tetanus, diphtheria, whooping cough, HPV-related cancers, COVID-19, and flu. Unity® Consortium offers digital and...
Earlier this month, we highlighted guidance for healthcare providers to protect children and adults against measles particularly before upcoming international travel plans. Here are those messages again in case you missed them: MMR Vaccination in Children MMR Vaccination in Adults We now have updated, free print materials available...
This presentation for healthcare providers will include updates, guidance, and recommendations from the Pennsylvania Department of Health, including subject matter experts from the Bureau of Epidemiology, the Bureau of Laboratories, and the Bureau of Immunizations. Agenda Update from the Department of Health on the current status of...
Mpox Vaccine Ordering: MLK Day 2025 Due to the upcoming Martin Luther King Jr. Day holiday, mpox vaccine orders can be placed until Tuesday, January 21, 2025 at 5:00PM. Remember to submit your temperatures to tempcheck@phila.gov and complete a reconciliation of vaccine on hand for your order to be...
Action Required: PhilaVax User Account Renewal Dear PhilaVax Users,The Philadelphia Department of Public Health (PDPH) Immunization Program is currently undergoing our annual PhilaVax user account renewal.All users must complete the user agreement for the 2025 calendar year for continued access to PhilaVax. All agreements must be...
Current Mpox Vaccine Inventory Expiring Soon All current mpox vaccine provided by PDPH will expire on October 31, 2024. Please make sure to dispose of the vaccine and mark your inventory as wasted in PhilaVax as appropriate. Use this Mpox Vaccine Wastage Guide for assistance. As a reminder, be sure to...
New Flu and COVID-19 Products Available VFC providers can now order: 2024-2025 Novavax COVID-19 products for 12 years and older Flucelvax (Sequirus) FluMist (AstraZeneca) Make sure that your EHR/EMR is set up to report this year’s COVID-19 products. These are the vaccines available: When placing COVID-19 orders, please remember: Complete a current COVID-19 reconciliation. Submit your...
Meningococcal B Vaccination: Bexsero Dosing On August 19, 2024, the Food and Drug Administration approved a new dosing schedule for GSK meningococcal B (menB) vaccine, Bexsero. The 1 month interval between dose 1 and 2 is no longer licensed, and has been replaced by a 6 month interval between...
